Episode 2 🗣🎬🎤🎧-  of the Disruptive Front with Daniel Kraft, MDis out NOW. Upload of the entire show and podcast version will be uploaded in a later post. We spoke #VR #AR #Digitalhealth #Diagnostics and Exponential Medicine

The Disruptive Front Episode 2 w/ Daniel Kraft M.D. Innovator | Entrepreneur | Physician | Futurist.  We had the opportunity to speak on very pressing topics in healthcare and whats-in in innovation and technology. We also had the chance to touch on diagnostic testing, the digital age of healthcare, and what companies are doing to change the playing field. 

We discussed:
1) VR 2) XPRIZE 3) Telehealth 4) Genetics 5) 3D Printing 6) Regulatory Affairs 7) Exponential medicine 8) TED Talks 9) Digital Health 10) Digital.health

https://danielkraftmd.net
https://www.digital.health

BIO
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University  since its inception in 2008, and is founder and chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.

He is heavily involved in digital health, founded Digital.Health, and is on the board of Healthy.io and advises several digital health related startups.  Daniel recently founded IntelliMedicine, focused on personalized, data driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies.